Evan Albright — Digest tagged "financing"Digest issues tagged #financing.https://www.evanalbright.com/en-usDeepSeek tops GPT-5.5 as npm backdoors hit Claude Code and obesity drug race heats up at ADAhttps://www.evanalbright.com/digest/2026-06-08/https://www.evanalbright.com/digest/2026-06-08/DeepSeek V4 Pro beat GPT-5.5 Pro on precision benchmarks this week, marking the latest round in the US-China model rivalry. A malware campaign hit 32 npm packages with roughly 117,000 weekly downloads, planting backdoors inside Claude Code startup settings. Pfizer's monthly obesity drug berobenatide continued to show promise in mid-stage data while Boehringer Ingelheim's survodutide disappointed on overall weight loss. Patrick Boyle examined what happens when a housing boom turns to bust, and Marc Rubinstein at Net Interest looked at the IPO readiness of SpaceX, Anthropic, and OpenAI.Mon, 08 Jun 2026 00:00:00 GMTaisoftwarepharmahealthtecheconomyllmdeepseeksecuritynpmobesityipohousingmyelomahepatitismodelsopen-sourcebenchmarksclinicalmacrochinasupply-chainclaudemalwaresandboxpythonwasmagentsopenaichatgptaccount-securitycode-qualitycontributionpolicyengineeringadoptiontechnical-debtteamsresearchinferencereasoningevalsgoogleoversighttransparencyspeculative-decodingkv-cachegpudatasetteeditingbackdoorworkflowruntimehealthcareprivacydeidentificationlocalapplicationcode-generationgamesmonitoringvllmoptimizationstructured-outputjsonmcpb2bintegrationcursorvscodeidecloudflarevitejavascriptbuild-toolsacquisitioncost-managementtokensenterpriseperformancesqlitearchitecturefrontendsynctestingautomationai-gatewaycloudsoftware-qualityinfrastructureobservabilityworkflowsproductiondeprecationmigrationanthropicsafetydesignclaude-codetoolingvisibilityimage-generationmemorytoolshepatitis-bantiviralcureinfectious-diseaseoncologyfdaregulationglp-1pfizeradaboehringerphase3lillyretatrutideebolaoutbreakcdcpublic-healthmodelingpancreatic-cancertangocombination-therapydrug-combinationgene-therapyfinancingnutritionmetabolic-healthhomeless-healthvascular-diseaseaccessliver-healthclinical-trialdosingvaccinesdemographicsnihphysician-advocacyfree-speechrfkautismhieresearch-ethicsgender-caredojpediatricshealth-policyinsuranceirsprofessional-societiesgender-healthnewslettertrendsprofessional-practicecompensationgovernancenonprofitmedicaidfraudclinical-practiceoccupational-healthcredentialingreal-estatecreditfinancial-crisisspacexcapital-marketscorporate-profitsmarginscompetitioneconomicsequitiesfiscal-policyrisktradeeuropeindustrial-policygeopoliticsimmigrationh1bproductivitylaborregional-economicsfertilitysmartphonesbehaviorcultureliteratureanalysistechnologylawinheritancefrancedrug-policyremote-workmental-healthinnovationroboticsdatarelocationentrepreneurshipinstitutionsinternationalcrisiscurrencyjapandebtpopulismpoliticsgdpmeasurement